Publication | Open Access

The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer

Breast OncologyMedicineGynecologyAdvanced BreastBreast CancerCancer TreatmentGranulocyte Colony-stimulating FactorOncologyRadiation OncologyGynecology OncologyOvarian Cancer